Targeted Technology Funds — Full Portfolio
24 tracked investments · listed companies and verified rows first
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries.
HealthtechMedical DevicesSports TechLondon, GB
Thomas James Smith(Founder)Horatio Nelson Smith(Co-founder)Deepak Nathin
PartnerAlan Dean· solo GP
Co-investorsAccess Venture PartnersAlphaDrive
Maker of the Spline-Fix External Fixator System for treating a range of bone fractures.
PartnerAlan Dean· solo GP
Aerin Medical develops non-invasive radiofrequency treatment systems for chronic nasal conditions, offering the VivAer stylus for nasal airway obstruction and RhinAer stylus for chronic rhinitis.
HealthtechMedical DevicesMountain View, US
Matt Brokaw(CEO & President)inDerrick Sung(Executive Officer)inMatthew Salkeld(Executive Officer)Irina Ridley(Executive Officer)inAndre Cheng(Executive Officer)inFred Dinger(Executive Officer, Director)in
PartnerAlan Dean· solo GP
Co-investorsLaunchCapitalOrbiMedQuesta CapitalAlly Bridge GroupHorizon
Medical device maker developing the Angel Catheter to prevent pulmonary embolism in critically ill patients; acquired by Mermaid Medical Group in 2018.
PartnerAlan Dean· solo GP
PartnerAlan Dean· solo GP
Provides technologies for detection, neutralization, and removal of endotoxin for bioresearch and bioprocess markets.
PartnerAlan Dean· solo GP
Developing the Surfacer Inside-Out Access Catheter System, a novel approach to central venous access.
San Antonio, US
James Clifton(Executive Officer)
BoardAlan Dean(Director)James Traa(Director)Robert Coleman(Director)
PartnerAlan Dean· solo GP
Bluegrass Vascular develops medical devices for restoring venous access in chronically occluded veins using an inside-out catheter approach.
HealthtechMedical DevicesLexington, US
BoardJohn Gurley(M.D.)
PartnerAlan Dean· solo GP
Medical technology company focused on tissue regeneration and repair using proprietary scaffold materials.
PartnerAlan Dean· solo GP
Provides high-throughput, high-accuracy automated cellular patch clamp testing instruments for drug development research.
PartnerAlan Dean· solo GP
BiotechSan Antonio, US
James R. Garvin(Chief Executive Officer, President, Secretary and Treasurer)
PartnerAlan Dean· solo GP
BiotechHouston, US
Frank Tufaro(Executive Officer, Director)Brian Mooney(Executive Officer)Isaac Cheng(Director)
BoardDaniel Watkins(Director)Reenie McCarthy(Director)Drew Pardoll(Director)
PartnerAlan Dean· solo GP
Co-investorsTexas Ventures
Designs and manufactures instruments and devices for sinus surgery; acquired by Smith & Nephew in 2013.
PartnerAlan Dean· solo GP
HealthtechSan Antonio, US
Dennis F. Filips(Executive Officer, Director)David Schneider(Executive Officer, Director)Maggie Pemberton(Executive Officer)Ian Atkinson(Executive Officer, Director)Philip W. Faris(Executive Officer, Director)
BoardPaul Castella(Executive Officer, Director)in
PartnerAlan Dean· solo GP
Medical device company providing the neoClose Trocar Port Closure System for laparoscopic and minimally invasive surgery.
PartnerAlan Dean· solo GP
Oxnard, US
Vito SAN FILIPPO(Executive Officer)MARIANNE THERESA CRONIN(Executive Officer, Director)
PartnerAlan Dean· solo GP
Enhances drug discovery by optimizing protein solubility and stability; acquired by InventaBioTech in 2016.
PartnerAlan Dean· solo GP
PartnerAlan Dean· solo GP
StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties.
BiotechHealthtechLongevityMedical DevicesSan Antonio, US
Chen Xiao-Dong(Director)Steven Davis(Co-founder)Xiao-Dong Chen(Co-founder)Travis Block(Chief Technology Officer)Jean Cheever(Director)Mark D Horsey(Executive Officer)
PartnerAlan Dean· solo GP
Developer of an intraosseous medicine technology platform; acquired by Teleflex in 2013.
PartnerAlan Dean· solo GP
Co-investorsTullis Health Investors
Mid-stage drug developer of botanical anti-viral topical prescription candidates for skin diseases; acquired by TFS Corporation in 2017.
BiotechSan Antonio, US
BoardAlan Dean(Director)Ian William David Clements(Executive Officer, Director)Paul Castella(Director)Gary Frashier(Director)
PartnerAlan Dean· solo GP
Xenex builds pulsed Xenon UV light disinfection robots that deactivate pathogens missed during manual cleaning, used by hospitals to reduce environmental contamination and healthcare-associated infections.
HealthtechMedical DevicesRobotics
Mark (Tuck) Stibich(Co-founder)Julie Stachowiak(Co-founder)Morris Miller(Co-founder & CEO)inMark "Tuck" Stibich(Founder & Chief Scientific Officer)
PartnerAlan Dean· solo GP
Co-investorsBattery VenturesTectonic Ventures
World leader in UV room disinfection robot systems for healthcare facilities.
PartnerAlan Dean· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.